Global mRNA Vaccines for Animals Market Research Report 2026(Status and Outlook)
mRNA vaccines for animals are a type of veterinary vaccine that use messenger RNA (mRNA) technology to stimulate an immune response against specific pathogens in livestock, pets, and other animals. These vaccines work by delivering synthetic mRNA encoding viral or bacterial antigens into the animal?s cells, prompting the immune system to recognize and fight the targeted disease. Compared to traditional vaccines, mRNA vaccines offer faster development timelines, improved efficacy, and the ability to rapidly adapt to emerging animal diseases. They are being explored for various applications, including livestock diseases (such as foot-and-mouth disease), zoonotic infections, and companion animal health.Market Development Opportunities & Main Driving FactorsmRNA vaccines for animals, as a new generation of biological products, are reshaping the global veterinary vaccine landscape with their rapid development, high specificity, and scalability. According to annual reports from animal health companies and brokerage research, the demand for epidemic prevention in the livestock industry continues to rise, particularly against transboundary infectious diseases and major animal epidemics, which accelerates investment in novel vaccines. The proven success of mRNA technology in human COVID-19 vaccines validates its potential in veterinary applications. Coupled with strong policy support for food safety, livestock modernization, and public health, the market expansion potential for animal mRNA vaccines is significant.Market Challenges, Risks, & RestraintsDespite promising prospects, animal mRNA vaccines face multiple challenges. Their storage, transportation, and mass production require stringent cold chain and advanced equipment, leading to higher costs compared to traditional vaccines. Regulatory frameworks remain immature, with varying standards for registration and safety validation across regions, adding uncertainty to commercialization. Additionally, the industry is dominated by multinational animal health giants with strong technological and financial advantages, creating barriers for smaller firms facing fierce competition and potential technological hurdles.Downstream Demand TrendsAs livestock farming becomes increasingly large-scale and intensive, and as consumer awareness of food safety and animal health grows, demand for safe and effective novel vaccines continues to rise. In particular, poultry, swine, and companion animal sectors exhibit strong demand for rapid-response vaccines against emerging diseases. Growing government investment in animal disease prevention and farmers? need to reduce losses and improve efficiency will further drive adoption. In the long term, animal mRNA vaccines are poised to become a critical technology supporting livestock stability and food supply security.
The global mRNA Vaccines for Animals market size was estimated at USD 81.02 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 61.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global mRNA Vaccines for Animals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global mRNA Vaccines for Animals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the mRNA Vaccines for Animals market.
Global mRNA Vaccines for Animals Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Ceva Animal Health
Merck Animal Health
Areterna
Bayer
BioNTech
Genvax Technologies
BioVenic
Moderna
Ruipu Biotechnology
Jinyu Bio-technology
Shanghai Shen Lian Biomedical
Suzhou Kerui Meide Biomedical Technology
Shanghai Rnacure Biopharma
Market Segmentation (by Type)
Non-replicating mRNA vaccines
Self-replicating mRNA vaccines
Market Segmentation (by Application)
Pigs
Poultry
Companion Animals
Ruminants
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the mRNA Vaccines for Animals Market
Overview of the regional outlook of the mRNA Vaccines for Animals Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Vaccines for Animals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of mRNA Vaccines for Animals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global mRNA Vaccines for Animals market size was estimated at USD 81.02 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 61.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global mRNA Vaccines for Animals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global mRNA Vaccines for Animals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the mRNA Vaccines for Animals market.
Global mRNA Vaccines for Animals Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Ceva Animal Health
Merck Animal Health
Areterna
Bayer
BioNTech
Genvax Technologies
BioVenic
Moderna
Ruipu Biotechnology
Jinyu Bio-technology
Shanghai Shen Lian Biomedical
Suzhou Kerui Meide Biomedical Technology
Shanghai Rnacure Biopharma
Market Segmentation (by Type)
Non-replicating mRNA vaccines
Self-replicating mRNA vaccines
Market Segmentation (by Application)
Pigs
Poultry
Companion Animals
Ruminants
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the mRNA Vaccines for Animals Market
Overview of the regional outlook of the mRNA Vaccines for Animals Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Vaccines for Animals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of mRNA Vaccines for Animals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of mRNA Vaccines for Animals
1.2 Key Market Segments
1.2.1 mRNA Vaccines for Animals Segment by Type
1.2.2 mRNA Vaccines for Animals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MRNA VACCINES FOR ANIMALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global mRNA Vaccines for Animals Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global mRNA Vaccines for Animals Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MRNA VACCINES FOR ANIMALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global mRNA Vaccines for Animals Product Life Cycle
3.3 Global mRNA Vaccines for Animals Sales by Manufacturers (2020-2025)
3.4 Global mRNA Vaccines for Animals Revenue Market Share by Manufacturers (2020-2025)
3.5 mRNA Vaccines for Animals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global mRNA Vaccines for Animals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 mRNA Vaccines for Animals Market Competitive Situation and Trends
3.8.1 mRNA Vaccines for Animals Market Concentration Rate
3.8.2 Global 5 and 10 Largest mRNA Vaccines for Animals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MRNA VACCINES FOR ANIMALS INDUSTRY CHAIN ANALYSIS
4.1 mRNA Vaccines for Animals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRNA VACCINES FOR ANIMALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global mRNA Vaccines for Animals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to mRNA Vaccines for Animals Market
5.7 ESG Ratings of Leading Companies
6 MRNA VACCINES FOR ANIMALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Vaccines for Animals Sales Market Share by Type (2020-2025)
6.3 Global mRNA Vaccines for Animals Market Size by Type (2020-2025)
6.4 Global mRNA Vaccines for Animals Price by Type (2020-2025)
7 MRNA VACCINES FOR ANIMALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Vaccines for Animals Market Sales by Application (2020-2025)
7.3 Global mRNA Vaccines for Animals Market Size (M USD) by Application (2020-2025)
7.4 Global mRNA Vaccines for Animals Sales Growth Rate by Application (2020-2025)
8 MRNA VACCINES FOR ANIMALS MARKET SALES BY REGION
8.1 Global mRNA Vaccines for Animals Sales by Region
8.1.1 Global mRNA Vaccines for Animals Sales by Region
8.1.2 Global mRNA Vaccines for Animals Sales Market Share by Region
8.2 Global mRNA Vaccines for Animals Market Size by Region
8.2.1 Global mRNA Vaccines for Animals Market Size by Region
8.2.2 Global mRNA Vaccines for Animals Market Size by Region
8.3 North America
8.3.1 North America mRNA Vaccines for Animals Sales by Country
8.3.2 North America mRNA Vaccines for Animals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe mRNA Vaccines for Animals Sales by Country
8.4.2 Europe mRNA Vaccines for Animals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific mRNA Vaccines for Animals Sales by Region
8.5.2 Asia Pacific mRNA Vaccines for Animals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America mRNA Vaccines for Animals Sales by Country
8.6.2 South America mRNA Vaccines for Animals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa mRNA Vaccines for Animals Sales by Region
8.7.2 Middle East and Africa mRNA Vaccines for Animals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MRNA VACCINES FOR ANIMALS MARKET PRODUCTION BY REGION
9.1 Global Production of mRNA Vaccines for Animals by Region(2020-2025)
9.2 Global mRNA Vaccines for Animals Revenue Market Share by Region (2020-2025)
9.3 Global mRNA Vaccines for Animals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America mRNA Vaccines for Animals Production
9.4.1 North America mRNA Vaccines for Animals Production Growth Rate (2020-2025)
9.4.2 North America mRNA Vaccines for Animals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe mRNA Vaccines for Animals Production
9.5.1 Europe mRNA Vaccines for Animals Production Growth Rate (2020-2025)
9.5.2 Europe mRNA Vaccines for Animals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan mRNA Vaccines for Animals Production (2020-2025)
9.6.1 Japan mRNA Vaccines for Animals Production Growth Rate (2020-2025)
9.6.2 Japan mRNA Vaccines for Animals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China mRNA Vaccines for Animals Production (2020-2025)
9.7.1 China mRNA Vaccines for Animals Production Growth Rate (2020-2025)
9.7.2 China mRNA Vaccines for Animals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Ceva Animal Health
10.1.1 Ceva Animal Health Basic Information
10.1.2 Ceva Animal Health mRNA Vaccines for Animals Product Overview
10.1.3 Ceva Animal Health mRNA Vaccines for Animals Product Market Performance
10.1.4 Ceva Animal Health Business Overview
10.1.5 Ceva Animal Health SWOT Analysis
10.1.6 Ceva Animal Health Recent Developments
10.2 Merck Animal Health
10.2.1 Merck Animal Health Basic Information
10.2.2 Merck Animal Health mRNA Vaccines for Animals Product Overview
10.2.3 Merck Animal Health mRNA Vaccines for Animals Product Market Performance
10.2.4 Merck Animal Health Business Overview
10.2.5 Merck Animal Health SWOT Analysis
10.2.6 Merck Animal Health Recent Developments
10.3 Areterna
10.3.1 Areterna Basic Information
10.3.2 Areterna mRNA Vaccines for Animals Product Overview
10.3.3 Areterna mRNA Vaccines for Animals Product Market Performance
10.3.4 Areterna Business Overview
10.3.5 Areterna SWOT Analysis
10.3.6 Areterna Recent Developments
10.4 Bayer
10.4.1 Bayer Basic Information
10.4.2 Bayer mRNA Vaccines for Animals Product Overview
10.4.3 Bayer mRNA Vaccines for Animals Product Market Performance
10.4.4 Bayer Business Overview
10.4.5 Bayer Recent Developments
10.5 BioNTech
10.5.1 BioNTech Basic Information
10.5.2 BioNTech mRNA Vaccines for Animals Product Overview
10.5.3 BioNTech mRNA Vaccines for Animals Product Market Performance
10.5.4 BioNTech Business Overview
10.5.5 BioNTech Recent Developments
10.6 Genvax Technologies
10.6.1 Genvax Technologies Basic Information
10.6.2 Genvax Technologies mRNA Vaccines for Animals Product Overview
10.6.3 Genvax Technologies mRNA Vaccines for Animals Product Market Performance
10.6.4 Genvax Technologies Business Overview
10.6.5 Genvax Technologies Recent Developments
10.7 BioVenic
10.7.1 BioVenic Basic Information
10.7.2 BioVenic mRNA Vaccines for Animals Product Overview
10.7.3 BioVenic mRNA Vaccines for Animals Product Market Performance
10.7.4 BioVenic Business Overview
10.7.5 BioVenic Recent Developments
10.8 Moderna
10.8.1 Moderna Basic Information
10.8.2 Moderna mRNA Vaccines for Animals Product Overview
10.8.3 Moderna mRNA Vaccines for Animals Product Market Performance
10.8.4 Moderna Business Overview
10.8.5 Moderna Recent Developments
10.9 Ruipu Biotechnology
10.9.1 Ruipu Biotechnology Basic Information
10.9.2 Ruipu Biotechnology mRNA Vaccines for Animals Product Overview
10.9.3 Ruipu Biotechnology mRNA Vaccines for Animals Product Market Performance
10.9.4 Ruipu Biotechnology Business Overview
10.9.5 Ruipu Biotechnology Recent Developments
10.10 Jinyu Bio-technology
10.10.1 Jinyu Bio-technology Basic Information
10.10.2 Jinyu Bio-technology mRNA Vaccines for Animals Product Overview
10.10.3 Jinyu Bio-technology mRNA Vaccines for Animals Product Market Performance
10.10.4 Jinyu Bio-technology Business Overview
10.10.5 Jinyu Bio-technology Recent Developments
10.11 Shanghai Shen Lian Biomedical
10.11.1 Shanghai Shen Lian Biomedical Basic Information
10.11.2 Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Product Overview
10.11.3 Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Product Market Performance
10.11.4 Shanghai Shen Lian Biomedical Business Overview
10.11.5 Shanghai Shen Lian Biomedical Recent Developments
10.12 Suzhou Kerui Meide Biomedical Technology
10.12.1 Suzhou Kerui Meide Biomedical Technology Basic Information
10.12.2 Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Product Overview
10.12.3 Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Product Market Performance
10.12.4 Suzhou Kerui Meide Biomedical Technology Business Overview
10.12.5 Suzhou Kerui Meide Biomedical Technology Recent Developments
10.13 Shanghai Rnacure Biopharma
10.13.1 Shanghai Rnacure Biopharma Basic Information
10.13.2 Shanghai Rnacure Biopharma mRNA Vaccines for Animals Product Overview
10.13.3 Shanghai Rnacure Biopharma mRNA Vaccines for Animals Product Market Performance
10.13.4 Shanghai Rnacure Biopharma Business Overview
10.13.5 Shanghai Rnacure Biopharma Recent Developments
11 MRNA VACCINES FOR ANIMALS MARKET FORECAST BY REGION
11.1 Global mRNA Vaccines for Animals Market Size Forecast
11.2 Global mRNA Vaccines for Animals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe mRNA Vaccines for Animals Market Size Forecast by Country
11.2.3 Asia Pacific mRNA Vaccines for Animals Market Size Forecast by Region
11.2.4 South America mRNA Vaccines for Animals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of mRNA Vaccines for Animals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global mRNA Vaccines for Animals Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of mRNA Vaccines for Animals by Type (2026-2035)
12.1.2 Global mRNA Vaccines for Animals Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of mRNA Vaccines for Animals by Type (2026-2035)
12.2 Global mRNA Vaccines for Animals Market Forecast by Application (2026-2035)
12.2.1 Global mRNA Vaccines for Animals Sales (K MT) Forecast by Application
12.2.2 Global mRNA Vaccines for Animals Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of mRNA Vaccines for Animals
1.2 Key Market Segments
1.2.1 mRNA Vaccines for Animals Segment by Type
1.2.2 mRNA Vaccines for Animals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MRNA VACCINES FOR ANIMALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global mRNA Vaccines for Animals Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global mRNA Vaccines for Animals Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MRNA VACCINES FOR ANIMALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global mRNA Vaccines for Animals Product Life Cycle
3.3 Global mRNA Vaccines for Animals Sales by Manufacturers (2020-2025)
3.4 Global mRNA Vaccines for Animals Revenue Market Share by Manufacturers (2020-2025)
3.5 mRNA Vaccines for Animals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global mRNA Vaccines for Animals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 mRNA Vaccines for Animals Market Competitive Situation and Trends
3.8.1 mRNA Vaccines for Animals Market Concentration Rate
3.8.2 Global 5 and 10 Largest mRNA Vaccines for Animals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MRNA VACCINES FOR ANIMALS INDUSTRY CHAIN ANALYSIS
4.1 mRNA Vaccines for Animals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRNA VACCINES FOR ANIMALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global mRNA Vaccines for Animals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to mRNA Vaccines for Animals Market
5.7 ESG Ratings of Leading Companies
6 MRNA VACCINES FOR ANIMALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Vaccines for Animals Sales Market Share by Type (2020-2025)
6.3 Global mRNA Vaccines for Animals Market Size by Type (2020-2025)
6.4 Global mRNA Vaccines for Animals Price by Type (2020-2025)
7 MRNA VACCINES FOR ANIMALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Vaccines for Animals Market Sales by Application (2020-2025)
7.3 Global mRNA Vaccines for Animals Market Size (M USD) by Application (2020-2025)
7.4 Global mRNA Vaccines for Animals Sales Growth Rate by Application (2020-2025)
8 MRNA VACCINES FOR ANIMALS MARKET SALES BY REGION
8.1 Global mRNA Vaccines for Animals Sales by Region
8.1.1 Global mRNA Vaccines for Animals Sales by Region
8.1.2 Global mRNA Vaccines for Animals Sales Market Share by Region
8.2 Global mRNA Vaccines for Animals Market Size by Region
8.2.1 Global mRNA Vaccines for Animals Market Size by Region
8.2.2 Global mRNA Vaccines for Animals Market Size by Region
8.3 North America
8.3.1 North America mRNA Vaccines for Animals Sales by Country
8.3.2 North America mRNA Vaccines for Animals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe mRNA Vaccines for Animals Sales by Country
8.4.2 Europe mRNA Vaccines for Animals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific mRNA Vaccines for Animals Sales by Region
8.5.2 Asia Pacific mRNA Vaccines for Animals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America mRNA Vaccines for Animals Sales by Country
8.6.2 South America mRNA Vaccines for Animals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa mRNA Vaccines for Animals Sales by Region
8.7.2 Middle East and Africa mRNA Vaccines for Animals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MRNA VACCINES FOR ANIMALS MARKET PRODUCTION BY REGION
9.1 Global Production of mRNA Vaccines for Animals by Region(2020-2025)
9.2 Global mRNA Vaccines for Animals Revenue Market Share by Region (2020-2025)
9.3 Global mRNA Vaccines for Animals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America mRNA Vaccines for Animals Production
9.4.1 North America mRNA Vaccines for Animals Production Growth Rate (2020-2025)
9.4.2 North America mRNA Vaccines for Animals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe mRNA Vaccines for Animals Production
9.5.1 Europe mRNA Vaccines for Animals Production Growth Rate (2020-2025)
9.5.2 Europe mRNA Vaccines for Animals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan mRNA Vaccines for Animals Production (2020-2025)
9.6.1 Japan mRNA Vaccines for Animals Production Growth Rate (2020-2025)
9.6.2 Japan mRNA Vaccines for Animals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China mRNA Vaccines for Animals Production (2020-2025)
9.7.1 China mRNA Vaccines for Animals Production Growth Rate (2020-2025)
9.7.2 China mRNA Vaccines for Animals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Ceva Animal Health
10.1.1 Ceva Animal Health Basic Information
10.1.2 Ceva Animal Health mRNA Vaccines for Animals Product Overview
10.1.3 Ceva Animal Health mRNA Vaccines for Animals Product Market Performance
10.1.4 Ceva Animal Health Business Overview
10.1.5 Ceva Animal Health SWOT Analysis
10.1.6 Ceva Animal Health Recent Developments
10.2 Merck Animal Health
10.2.1 Merck Animal Health Basic Information
10.2.2 Merck Animal Health mRNA Vaccines for Animals Product Overview
10.2.3 Merck Animal Health mRNA Vaccines for Animals Product Market Performance
10.2.4 Merck Animal Health Business Overview
10.2.5 Merck Animal Health SWOT Analysis
10.2.6 Merck Animal Health Recent Developments
10.3 Areterna
10.3.1 Areterna Basic Information
10.3.2 Areterna mRNA Vaccines for Animals Product Overview
10.3.3 Areterna mRNA Vaccines for Animals Product Market Performance
10.3.4 Areterna Business Overview
10.3.5 Areterna SWOT Analysis
10.3.6 Areterna Recent Developments
10.4 Bayer
10.4.1 Bayer Basic Information
10.4.2 Bayer mRNA Vaccines for Animals Product Overview
10.4.3 Bayer mRNA Vaccines for Animals Product Market Performance
10.4.4 Bayer Business Overview
10.4.5 Bayer Recent Developments
10.5 BioNTech
10.5.1 BioNTech Basic Information
10.5.2 BioNTech mRNA Vaccines for Animals Product Overview
10.5.3 BioNTech mRNA Vaccines for Animals Product Market Performance
10.5.4 BioNTech Business Overview
10.5.5 BioNTech Recent Developments
10.6 Genvax Technologies
10.6.1 Genvax Technologies Basic Information
10.6.2 Genvax Technologies mRNA Vaccines for Animals Product Overview
10.6.3 Genvax Technologies mRNA Vaccines for Animals Product Market Performance
10.6.4 Genvax Technologies Business Overview
10.6.5 Genvax Technologies Recent Developments
10.7 BioVenic
10.7.1 BioVenic Basic Information
10.7.2 BioVenic mRNA Vaccines for Animals Product Overview
10.7.3 BioVenic mRNA Vaccines for Animals Product Market Performance
10.7.4 BioVenic Business Overview
10.7.5 BioVenic Recent Developments
10.8 Moderna
10.8.1 Moderna Basic Information
10.8.2 Moderna mRNA Vaccines for Animals Product Overview
10.8.3 Moderna mRNA Vaccines for Animals Product Market Performance
10.8.4 Moderna Business Overview
10.8.5 Moderna Recent Developments
10.9 Ruipu Biotechnology
10.9.1 Ruipu Biotechnology Basic Information
10.9.2 Ruipu Biotechnology mRNA Vaccines for Animals Product Overview
10.9.3 Ruipu Biotechnology mRNA Vaccines for Animals Product Market Performance
10.9.4 Ruipu Biotechnology Business Overview
10.9.5 Ruipu Biotechnology Recent Developments
10.10 Jinyu Bio-technology
10.10.1 Jinyu Bio-technology Basic Information
10.10.2 Jinyu Bio-technology mRNA Vaccines for Animals Product Overview
10.10.3 Jinyu Bio-technology mRNA Vaccines for Animals Product Market Performance
10.10.4 Jinyu Bio-technology Business Overview
10.10.5 Jinyu Bio-technology Recent Developments
10.11 Shanghai Shen Lian Biomedical
10.11.1 Shanghai Shen Lian Biomedical Basic Information
10.11.2 Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Product Overview
10.11.3 Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Product Market Performance
10.11.4 Shanghai Shen Lian Biomedical Business Overview
10.11.5 Shanghai Shen Lian Biomedical Recent Developments
10.12 Suzhou Kerui Meide Biomedical Technology
10.12.1 Suzhou Kerui Meide Biomedical Technology Basic Information
10.12.2 Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Product Overview
10.12.3 Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Product Market Performance
10.12.4 Suzhou Kerui Meide Biomedical Technology Business Overview
10.12.5 Suzhou Kerui Meide Biomedical Technology Recent Developments
10.13 Shanghai Rnacure Biopharma
10.13.1 Shanghai Rnacure Biopharma Basic Information
10.13.2 Shanghai Rnacure Biopharma mRNA Vaccines for Animals Product Overview
10.13.3 Shanghai Rnacure Biopharma mRNA Vaccines for Animals Product Market Performance
10.13.4 Shanghai Rnacure Biopharma Business Overview
10.13.5 Shanghai Rnacure Biopharma Recent Developments
11 MRNA VACCINES FOR ANIMALS MARKET FORECAST BY REGION
11.1 Global mRNA Vaccines for Animals Market Size Forecast
11.2 Global mRNA Vaccines for Animals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe mRNA Vaccines for Animals Market Size Forecast by Country
11.2.3 Asia Pacific mRNA Vaccines for Animals Market Size Forecast by Region
11.2.4 South America mRNA Vaccines for Animals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of mRNA Vaccines for Animals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global mRNA Vaccines for Animals Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of mRNA Vaccines for Animals by Type (2026-2035)
12.1.2 Global mRNA Vaccines for Animals Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of mRNA Vaccines for Animals by Type (2026-2035)
12.2 Global mRNA Vaccines for Animals Market Forecast by Application (2026-2035)
12.2.1 Global mRNA Vaccines for Animals Sales (K MT) Forecast by Application
12.2.2 Global mRNA Vaccines for Animals Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global mRNA Vaccines for Animals Market Size by Type (M USD)
Table 4. Global mRNA Vaccines for Animals Market Size by Application
Table 5. mRNA Vaccines for Animals Market Size Comparison by Region (M USD)
Table 6. Global mRNA Vaccines for Animals Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global mRNA Vaccines for Animals Sales Market Share by Manufacturers (2020-2025)
Table 8. Global mRNA Vaccines for Animals Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global mRNA Vaccines for Animals Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines for Animals as of 2025)
Table 11. Global Market mRNA Vaccines for Animals Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global mRNA Vaccines for Animals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA Vaccines for Animals Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global mRNA Vaccines for Animals Sales by Type (K MT)
Table 27. Global mRNA Vaccines for Animals Market Size by Type (M USD)
Table 28. Global mRNA Vaccines for Animals Sales (K MT) by Type (2020-2025)
Table 29. Global mRNA Vaccines for Animals Sales Market Share by Type (2020-2025)
Table 30. Global mRNA Vaccines for Animals Market Size (M USD) by Type (2020-2025)
Table 31. Global mRNA Vaccines for Animals Market Share by Type (2020-2025)
Table 32. Global mRNA Vaccines for Animals Price (USD/KG) by Type (2020-2025)
Table 33. Global mRNA Vaccines for Animals Sales (K MT) by Application
Table 34. Global mRNA Vaccines for Animals Market Size by Application
Table 35. Global mRNA Vaccines for Animals Sales by Application (2020-2025) & (K MT)
Table 36. Global mRNA Vaccines for Animals Sales Market Share by Application (2020-2025)
Table 37. Global mRNA Vaccines for Animals Market Size by Application (2020-2025) & (M USD)
Table 38. Global mRNA Vaccines for Animals Market Share by Application (2020-2025)
Table 39. Global mRNA Vaccines for Animals Sales Growth Rate by Application (2020-2025)
Table 40. Global mRNA Vaccines for Animals Sales by Region (2020-2025) & (K MT)
Table 41. Global mRNA Vaccines for Animals Sales Market Share by Region (2020-2025)
Table 42. Global mRNA Vaccines for Animals Market Size by Region (2020-2025) & (M USD)
Table 43. Global mRNA Vaccines for Animals Market Size by Region (2020-2025)
Table 44. North America mRNA Vaccines for Animals Sales by Country (2020-2025) & (K MT)
Table 45. North America mRNA Vaccines for Animals Market Size by Country (2020-2025) & (M USD)
Table 46. Europe mRNA Vaccines for Animals Sales by Country (2020-2025) & (K MT)
Table 47. Europe mRNA Vaccines for Animals Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific mRNA Vaccines for Animals Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific mRNA Vaccines for Animals Market Size by Region (2020-2025) & (M USD)
Table 50. South America mRNA Vaccines for Animals Sales by Country (2020-2025) & (K MT)
Table 51. South America mRNA Vaccines for Animals Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa mRNA Vaccines for Animals Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa mRNA Vaccines for Animals Market Size by Region (2020-2025) & (M USD)
Table 54. Global mRNA Vaccines for Animals Production (K MT) by Region(2020-2025)
Table 55. Global mRNA Vaccines for Animals Revenue (US$ Million) by Region (2020-2025)
Table 56. Global mRNA Vaccines for Animals Revenue Market Share by Region (2020-2025)
Table 57. Global mRNA Vaccines for Animals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America mRNA Vaccines for Animals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe mRNA Vaccines for Animals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan mRNA Vaccines for Animals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China mRNA Vaccines for Animals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Ceva Animal Health Basic Information
Table 63. Ceva Animal Health mRNA Vaccines for Animals Product Overview
Table 64. Ceva Animal Health mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Ceva Animal Health Business Overview
Table 66. Ceva Animal Health SWOT Analysis
Table 67. Ceva Animal Health Recent Developments
Table 68. Merck Animal Health Basic Information
Table 69. Merck Animal Health mRNA Vaccines for Animals Product Overview
Table 70. Merck Animal Health mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Merck Animal Health Business Overview
Table 72. Merck Animal Health SWOT Analysis
Table 73. Merck Animal Health Recent Developments
Table 74. Areterna Basic Information
Table 75. Areterna mRNA Vaccines for Animals Product Overview
Table 76. Areterna mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Areterna Business Overview
Table 78. Areterna SWOT Analysis
Table 79. Areterna Recent Developments
Table 80. Bayer Basic Information
Table 81. Bayer mRNA Vaccines for Animals Product Overview
Table 82. Bayer mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bayer Business Overview
Table 84. Bayer Recent Developments
Table 85. BioNTech Basic Information
Table 86. BioNTech mRNA Vaccines for Animals Product Overview
Table 87. BioNTech mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. BioNTech Business Overview
Table 89. BioNTech Recent Developments
Table 90. Genvax Technologies Basic Information
Table 91. Genvax Technologies mRNA Vaccines for Animals Product Overview
Table 92. Genvax Technologies mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Genvax Technologies Business Overview
Table 94. Genvax Technologies Recent Developments
Table 95. BioVenic Basic Information
Table 96. BioVenic mRNA Vaccines for Animals Product Overview
Table 97. BioVenic mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. BioVenic Business Overview
Table 99. BioVenic Recent Developments
Table 100. Moderna Basic Information
Table 101. Moderna mRNA Vaccines for Animals Product Overview
Table 102. Moderna mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Moderna Business Overview
Table 104. Moderna Recent Developments
Table 105. Ruipu Biotechnology Basic Information
Table 106. Ruipu Biotechnology mRNA Vaccines for Animals Product Overview
Table 107. Ruipu Biotechnology mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Ruipu Biotechnology Business Overview
Table 109. Ruipu Biotechnology Recent Developments
Table 110. Jinyu Bio-technology Basic Information
Table 111. Jinyu Bio-technology mRNA Vaccines for Animals Product Overview
Table 112. Jinyu Bio-technology mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Jinyu Bio-technology Business Overview
Table 114. Jinyu Bio-technology Recent Developments
Table 115. Shanghai Shen Lian Biomedical Basic Information
Table 116. Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Product Overview
Table 117. Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Shanghai Shen Lian Biomedical Business Overview
Table 119. Shanghai Shen Lian Biomedical Recent Developments
Table 120. Suzhou Kerui Meide Biomedical Technology Basic Information
Table 121. Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Product Overview
Table 122. Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Suzhou Kerui Meide Biomedical Technology Business Overview
Table 124. Suzhou Kerui Meide Biomedical Technology Recent Developments
Table 125. Shanghai Rnacure Biopharma Basic Information
Table 126. Shanghai Rnacure Biopharma mRNA Vaccines for Animals Product Overview
Table 127. Shanghai Rnacure Biopharma mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Shanghai Rnacure Biopharma Business Overview
Table 129. Shanghai Rnacure Biopharma Recent Developments
Table 130. Global mRNA Vaccines for Animals Sales Forecast by Region (2026-2035) & (K MT)
Table 131. Global mRNA Vaccines for Animals Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America mRNA Vaccines for Animals Sales Forecast by Country (2026-2035) & (K MT)
Table 133. North America mRNA Vaccines for Animals Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe mRNA Vaccines for Animals Sales Forecast by Country (2026-2035) & (K MT)
Table 135. Europe mRNA Vaccines for Animals Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific mRNA Vaccines for Animals Sales Forecast by Region (2026-2035) & (K MT)
Table 137. Asia Pacific mRNA Vaccines for Animals Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America mRNA Vaccines for Animals Sales Forecast by Country (2026-2035) & (K MT)
Table 139. South America mRNA Vaccines for Animals Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa mRNA Vaccines for Animals Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa mRNA Vaccines for Animals Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global mRNA Vaccines for Animals Sales Forecast by Type (2026-2035) & (K MT)
Table 143. Global mRNA Vaccines for Animals Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global mRNA Vaccines for Animals Price Forecast by Type (2026-2035) & (USD/KG)
Table 145. Global mRNA Vaccines for Animals Sales (K MT) Forecast by Application (2026-2035)
Table 146. Global mRNA Vaccines for Animals Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global mRNA Vaccines for Animals Market Size by Type (M USD)
Table 4. Global mRNA Vaccines for Animals Market Size by Application
Table 5. mRNA Vaccines for Animals Market Size Comparison by Region (M USD)
Table 6. Global mRNA Vaccines for Animals Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global mRNA Vaccines for Animals Sales Market Share by Manufacturers (2020-2025)
Table 8. Global mRNA Vaccines for Animals Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global mRNA Vaccines for Animals Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines for Animals as of 2025)
Table 11. Global Market mRNA Vaccines for Animals Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global mRNA Vaccines for Animals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA Vaccines for Animals Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global mRNA Vaccines for Animals Sales by Type (K MT)
Table 27. Global mRNA Vaccines for Animals Market Size by Type (M USD)
Table 28. Global mRNA Vaccines for Animals Sales (K MT) by Type (2020-2025)
Table 29. Global mRNA Vaccines for Animals Sales Market Share by Type (2020-2025)
Table 30. Global mRNA Vaccines for Animals Market Size (M USD) by Type (2020-2025)
Table 31. Global mRNA Vaccines for Animals Market Share by Type (2020-2025)
Table 32. Global mRNA Vaccines for Animals Price (USD/KG) by Type (2020-2025)
Table 33. Global mRNA Vaccines for Animals Sales (K MT) by Application
Table 34. Global mRNA Vaccines for Animals Market Size by Application
Table 35. Global mRNA Vaccines for Animals Sales by Application (2020-2025) & (K MT)
Table 36. Global mRNA Vaccines for Animals Sales Market Share by Application (2020-2025)
Table 37. Global mRNA Vaccines for Animals Market Size by Application (2020-2025) & (M USD)
Table 38. Global mRNA Vaccines for Animals Market Share by Application (2020-2025)
Table 39. Global mRNA Vaccines for Animals Sales Growth Rate by Application (2020-2025)
Table 40. Global mRNA Vaccines for Animals Sales by Region (2020-2025) & (K MT)
Table 41. Global mRNA Vaccines for Animals Sales Market Share by Region (2020-2025)
Table 42. Global mRNA Vaccines for Animals Market Size by Region (2020-2025) & (M USD)
Table 43. Global mRNA Vaccines for Animals Market Size by Region (2020-2025)
Table 44. North America mRNA Vaccines for Animals Sales by Country (2020-2025) & (K MT)
Table 45. North America mRNA Vaccines for Animals Market Size by Country (2020-2025) & (M USD)
Table 46. Europe mRNA Vaccines for Animals Sales by Country (2020-2025) & (K MT)
Table 47. Europe mRNA Vaccines for Animals Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific mRNA Vaccines for Animals Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific mRNA Vaccines for Animals Market Size by Region (2020-2025) & (M USD)
Table 50. South America mRNA Vaccines for Animals Sales by Country (2020-2025) & (K MT)
Table 51. South America mRNA Vaccines for Animals Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa mRNA Vaccines for Animals Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa mRNA Vaccines for Animals Market Size by Region (2020-2025) & (M USD)
Table 54. Global mRNA Vaccines for Animals Production (K MT) by Region(2020-2025)
Table 55. Global mRNA Vaccines for Animals Revenue (US$ Million) by Region (2020-2025)
Table 56. Global mRNA Vaccines for Animals Revenue Market Share by Region (2020-2025)
Table 57. Global mRNA Vaccines for Animals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America mRNA Vaccines for Animals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe mRNA Vaccines for Animals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan mRNA Vaccines for Animals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China mRNA Vaccines for Animals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Ceva Animal Health Basic Information
Table 63. Ceva Animal Health mRNA Vaccines for Animals Product Overview
Table 64. Ceva Animal Health mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Ceva Animal Health Business Overview
Table 66. Ceva Animal Health SWOT Analysis
Table 67. Ceva Animal Health Recent Developments
Table 68. Merck Animal Health Basic Information
Table 69. Merck Animal Health mRNA Vaccines for Animals Product Overview
Table 70. Merck Animal Health mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Merck Animal Health Business Overview
Table 72. Merck Animal Health SWOT Analysis
Table 73. Merck Animal Health Recent Developments
Table 74. Areterna Basic Information
Table 75. Areterna mRNA Vaccines for Animals Product Overview
Table 76. Areterna mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Areterna Business Overview
Table 78. Areterna SWOT Analysis
Table 79. Areterna Recent Developments
Table 80. Bayer Basic Information
Table 81. Bayer mRNA Vaccines for Animals Product Overview
Table 82. Bayer mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bayer Business Overview
Table 84. Bayer Recent Developments
Table 85. BioNTech Basic Information
Table 86. BioNTech mRNA Vaccines for Animals Product Overview
Table 87. BioNTech mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. BioNTech Business Overview
Table 89. BioNTech Recent Developments
Table 90. Genvax Technologies Basic Information
Table 91. Genvax Technologies mRNA Vaccines for Animals Product Overview
Table 92. Genvax Technologies mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Genvax Technologies Business Overview
Table 94. Genvax Technologies Recent Developments
Table 95. BioVenic Basic Information
Table 96. BioVenic mRNA Vaccines for Animals Product Overview
Table 97. BioVenic mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. BioVenic Business Overview
Table 99. BioVenic Recent Developments
Table 100. Moderna Basic Information
Table 101. Moderna mRNA Vaccines for Animals Product Overview
Table 102. Moderna mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Moderna Business Overview
Table 104. Moderna Recent Developments
Table 105. Ruipu Biotechnology Basic Information
Table 106. Ruipu Biotechnology mRNA Vaccines for Animals Product Overview
Table 107. Ruipu Biotechnology mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Ruipu Biotechnology Business Overview
Table 109. Ruipu Biotechnology Recent Developments
Table 110. Jinyu Bio-technology Basic Information
Table 111. Jinyu Bio-technology mRNA Vaccines for Animals Product Overview
Table 112. Jinyu Bio-technology mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Jinyu Bio-technology Business Overview
Table 114. Jinyu Bio-technology Recent Developments
Table 115. Shanghai Shen Lian Biomedical Basic Information
Table 116. Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Product Overview
Table 117. Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Shanghai Shen Lian Biomedical Business Overview
Table 119. Shanghai Shen Lian Biomedical Recent Developments
Table 120. Suzhou Kerui Meide Biomedical Technology Basic Information
Table 121. Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Product Overview
Table 122. Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Suzhou Kerui Meide Biomedical Technology Business Overview
Table 124. Suzhou Kerui Meide Biomedical Technology Recent Developments
Table 125. Shanghai Rnacure Biopharma Basic Information
Table 126. Shanghai Rnacure Biopharma mRNA Vaccines for Animals Product Overview
Table 127. Shanghai Rnacure Biopharma mRNA Vaccines for Animals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Shanghai Rnacure Biopharma Business Overview
Table 129. Shanghai Rnacure Biopharma Recent Developments
Table 130. Global mRNA Vaccines for Animals Sales Forecast by Region (2026-2035) & (K MT)
Table 131. Global mRNA Vaccines for Animals Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America mRNA Vaccines for Animals Sales Forecast by Country (2026-2035) & (K MT)
Table 133. North America mRNA Vaccines for Animals Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe mRNA Vaccines for Animals Sales Forecast by Country (2026-2035) & (K MT)
Table 135. Europe mRNA Vaccines for Animals Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific mRNA Vaccines for Animals Sales Forecast by Region (2026-2035) & (K MT)
Table 137. Asia Pacific mRNA Vaccines for Animals Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America mRNA Vaccines for Animals Sales Forecast by Country (2026-2035) & (K MT)
Table 139. South America mRNA Vaccines for Animals Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa mRNA Vaccines for Animals Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa mRNA Vaccines for Animals Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global mRNA Vaccines for Animals Sales Forecast by Type (2026-2035) & (K MT)
Table 143. Global mRNA Vaccines for Animals Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global mRNA Vaccines for Animals Price Forecast by Type (2026-2035) & (USD/KG)
Table 145. Global mRNA Vaccines for Animals Sales (K MT) Forecast by Application (2026-2035)
Table 146. Global mRNA Vaccines for Animals Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of mRNA Vaccines for Animals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Vaccines for Animals Market Size (M USD), 2025-2035
Figure 5. Global mRNA Vaccines for Animals Market Size (M USD) (2020-2035)
Figure 6. Global mRNA Vaccines for Animals Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Vaccines for Animals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global mRNA Vaccines for Animals Product Life Cycle
Figure 13. mRNA Vaccines for Animals Sales Share by Manufacturers in 2025
Figure 14. Global mRNA Vaccines for Animals Revenue Share by Manufacturers in 2025
Figure 15. mRNA Vaccines for Animals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market mRNA Vaccines for Animals Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by mRNA Vaccines for Animals Revenue in 2025
Figure 18. Industry Chain Map of mRNA Vaccines for Animals
Figure 19. Global mRNA Vaccines for Animals Market PEST Analysis
Figure 20. Global mRNA Vaccines for Animals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global mRNA Vaccines for Animals Market Share by Type
Figure 27. Sales Market Share of mRNA Vaccines for Animals by Type (2020-2025)
Figure 28. Sales Market Share of mRNA Vaccines for Animals by Type in 2025
Figure 29. Market Share of mRNA Vaccines for Animals by Type (2020-2025)
Figure 30. Market Share of mRNA Vaccines for Animals by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global mRNA Vaccines for Animals Market Share by Application
Figure 33. Global mRNA Vaccines for Animals Sales Market Share by Application (2020-2025)
Figure 34. Global mRNA Vaccines for Animals Sales Market Share by Application in 2025
Figure 35. Global mRNA Vaccines for Animals Market Share by Application (2020-2025)
Figure 36. Global mRNA Vaccines for Animals Market Share by Application in 2025
Figure 37. Global mRNA Vaccines for Animals Sales Growth Rate by Application (2020-2025)
Figure 38. Global mRNA Vaccines for Animals Sales Market Share by Region (2020-2025)
Figure 39. Global mRNA Vaccines for Animals Market Size by Region (2020-2025)
Figure 40. North America mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America mRNA Vaccines for Animals Sales Market Share by Country in 2024
Figure 43. North America mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America mRNA Vaccines for Animals Market Size by Country in 2024
Figure 45. U.S. mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada mRNA Vaccines for Animals Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada mRNA Vaccines for Animals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico mRNA Vaccines for Animals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico mRNA Vaccines for Animals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe mRNA Vaccines for Animals Sales Market Share by Country in 2024
Figure 53. Europe mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe mRNA Vaccines for Animals Market Size by Country in 2024
Figure 55. Germany mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific mRNA Vaccines for Animals Sales and Growth Rate (K MT)
Figure 66. Asia Pacific mRNA Vaccines for Animals Sales Market Share by Region in 2024
Figure 67. Asia Pacific mRNA Vaccines for Animals Market Size by Region in 2024
Figure 68. China mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America mRNA Vaccines for Animals Sales and Growth Rate (K MT)
Figure 79. South America mRNA Vaccines for Animals Sales Market Share by Country in 2024
Figure 80. South America mRNA Vaccines for Animals Market Size and Growth Rate (M USD)
Figure 81. South America mRNA Vaccines for Animals Market Size by Country in 2024
Figure 82. Brazil mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa mRNA Vaccines for Animals Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa mRNA Vaccines for Animals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa mRNA Vaccines for Animals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa mRNA Vaccines for Animals Market Size by Region in 2024
Figure 92. Saudi Arabia mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global mRNA Vaccines for Animals Production Market Share by Region (2020-2025)
Figure 103. North America mRNA Vaccines for Animals Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe mRNA Vaccines for Animals Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan mRNA Vaccines for Animals Production (K MT) Growth Rate (2020-2025)
Figure 106. China mRNA Vaccines for Animals Production (K MT) Growth Rate (2020-2025)
Figure 107. Global mRNA Vaccines for Animals Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global mRNA Vaccines for Animals Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global mRNA Vaccines for Animals Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global mRNA Vaccines for Animals Market Share Forecast by Type (2026-2035)
Figure 111. Global mRNA Vaccines for Animals Sales Forecast by Application (2026-2035)
Figure 112. Global mRNA Vaccines for Animals Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of mRNA Vaccines for Animals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Vaccines for Animals Market Size (M USD), 2025-2035
Figure 5. Global mRNA Vaccines for Animals Market Size (M USD) (2020-2035)
Figure 6. Global mRNA Vaccines for Animals Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Vaccines for Animals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global mRNA Vaccines for Animals Product Life Cycle
Figure 13. mRNA Vaccines for Animals Sales Share by Manufacturers in 2025
Figure 14. Global mRNA Vaccines for Animals Revenue Share by Manufacturers in 2025
Figure 15. mRNA Vaccines for Animals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market mRNA Vaccines for Animals Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by mRNA Vaccines for Animals Revenue in 2025
Figure 18. Industry Chain Map of mRNA Vaccines for Animals
Figure 19. Global mRNA Vaccines for Animals Market PEST Analysis
Figure 20. Global mRNA Vaccines for Animals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global mRNA Vaccines for Animals Market Share by Type
Figure 27. Sales Market Share of mRNA Vaccines for Animals by Type (2020-2025)
Figure 28. Sales Market Share of mRNA Vaccines for Animals by Type in 2025
Figure 29. Market Share of mRNA Vaccines for Animals by Type (2020-2025)
Figure 30. Market Share of mRNA Vaccines for Animals by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global mRNA Vaccines for Animals Market Share by Application
Figure 33. Global mRNA Vaccines for Animals Sales Market Share by Application (2020-2025)
Figure 34. Global mRNA Vaccines for Animals Sales Market Share by Application in 2025
Figure 35. Global mRNA Vaccines for Animals Market Share by Application (2020-2025)
Figure 36. Global mRNA Vaccines for Animals Market Share by Application in 2025
Figure 37. Global mRNA Vaccines for Animals Sales Growth Rate by Application (2020-2025)
Figure 38. Global mRNA Vaccines for Animals Sales Market Share by Region (2020-2025)
Figure 39. Global mRNA Vaccines for Animals Market Size by Region (2020-2025)
Figure 40. North America mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America mRNA Vaccines for Animals Sales Market Share by Country in 2024
Figure 43. North America mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America mRNA Vaccines for Animals Market Size by Country in 2024
Figure 45. U.S. mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada mRNA Vaccines for Animals Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada mRNA Vaccines for Animals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico mRNA Vaccines for Animals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico mRNA Vaccines for Animals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe mRNA Vaccines for Animals Sales Market Share by Country in 2024
Figure 53. Europe mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe mRNA Vaccines for Animals Market Size by Country in 2024
Figure 55. Germany mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific mRNA Vaccines for Animals Sales and Growth Rate (K MT)
Figure 66. Asia Pacific mRNA Vaccines for Animals Sales Market Share by Region in 2024
Figure 67. Asia Pacific mRNA Vaccines for Animals Market Size by Region in 2024
Figure 68. China mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America mRNA Vaccines for Animals Sales and Growth Rate (K MT)
Figure 79. South America mRNA Vaccines for Animals Sales Market Share by Country in 2024
Figure 80. South America mRNA Vaccines for Animals Market Size and Growth Rate (M USD)
Figure 81. South America mRNA Vaccines for Animals Market Size by Country in 2024
Figure 82. Brazil mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa mRNA Vaccines for Animals Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa mRNA Vaccines for Animals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa mRNA Vaccines for Animals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa mRNA Vaccines for Animals Market Size by Region in 2024
Figure 92. Saudi Arabia mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa mRNA Vaccines for Animals Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa mRNA Vaccines for Animals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global mRNA Vaccines for Animals Production Market Share by Region (2020-2025)
Figure 103. North America mRNA Vaccines for Animals Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe mRNA Vaccines for Animals Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan mRNA Vaccines for Animals Production (K MT) Growth Rate (2020-2025)
Figure 106. China mRNA Vaccines for Animals Production (K MT) Growth Rate (2020-2025)
Figure 107. Global mRNA Vaccines for Animals Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global mRNA Vaccines for Animals Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global mRNA Vaccines for Animals Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global mRNA Vaccines for Animals Market Share Forecast by Type (2026-2035)
Figure 111. Global mRNA Vaccines for Animals Sales Forecast by Application (2026-2035)
Figure 112. Global mRNA Vaccines for Animals Market Share Forecast by Application (2026-2035)
